Anne Pumfery
|
|
|
|
|
|
|
|
|
| Connie Jung | ||||||||
| Connie Jung is currently a Regulatory Review Officer in the Division of Bioequivalence, Office of Generic Drugs (OGD), Center for Drug Evaluation and Research at the U.S. Food and Drug Administration (FDA). She received her B.S. in Pharmacy from The Ohio State University, College of Pharmacy in 1993 and conducted undergraduate research using aqueous polymer systems for optimizing drug solubility. She received her Ph.D. in Pharmaceutical Sciences from the University of Cincinnati, College of Pharmacy in 2000. Her research included in vitro cell culture of human skin keratinocytes, and in vitro and in vivo percutaneous absorption and metabolism of dermal compounds in rat and human skin. Her Public Health Service (US PHS) career began in 1999 when she joined the FDA as a researcher in the Center for Food Safety and Applied Nutrition, Office of Cosmetics and Colors, Toxicology Branch, investigating potential skin absorption and metabolism of compounds contained in cosmetic products for safety concersn. She joined OGD and the US PHS Commissioned Corps in 2003 as a bioequivalence reviwer of abbreviated new drug applications (ANDAs) for generic drug products. She continues to practice pharmacy on a part-time basis. Connie has been a member of GWIS since 2000 and is currently the GWIS, Omicron Chapter Treasurer. | ||||||||
| Web Master Anne Pumfery |
||||||||
| Home | ||||||||